Cargando…
Mutant p53 induces EZH2 expression and promotes epithelial–mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing
The tumor suppressor p53 and the transcriptional repressor Enhancer of Zeste Homolog 2 (EZH2) have both been implicated in the regulation of epithelial-mesenchymal transition (EMT) and tumor metastasis via their impacts on microRNA expression. Here, we report that mutant p53 (mutp53) promotes EMT in...
Autores principales: | Jiang, Fei-Zhou, He, Yin-Yan, Wang, Hui-Hui, Zhang, Hui-Lin, Zhang, Jian, Yan, Xiao-Fang, Wang, Xiao-Jun, Che, Qi, Ke, Jie-Qi, Chen, Zheng, Tong, Huan, Zhang, Yong-Li, Wang, Fang-Yuan, Li, Yi-Ran, Wan, Xiao-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792583/ https://www.ncbi.nlm.nih.gov/pubmed/26587974 |
Ejemplares similares
-
Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity
por: Gurtner, Aymone, et al.
Publicado: (2016) -
Differential regulation of the REGγ–proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells
por: Ali, Amjad, et al.
Publicado: (2013) -
The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
por: Li, Dan-Dan, et al.
Publicado: (2012) -
Mutant p53 Cooperates with Knockdown of Endogenous Wild-Type p53 to Disrupt Tubulogenesis in Madin-Darby Canine Kidney Cells
por: Zhang, Yanhong, et al.
Publicado: (2013) -
Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
por: Qin, Jiang-Jiang, et al.
Publicado: (2018)